Nu-Med (NUMD) 0.3490 $NUMD
Nu-Med Plus Announces Investigational Study of Stored Blood as a New Path for Their NO Devices
Marketwire Canada - Tue May 10, 7:02AM CDT
SALT LAKE CITY, UT--(Marketwired - May 10, 2016) - Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announces they are embarking on a new investigational study applying their patent pending nitric oxide delivery devices to the protection of stored blood. Prior investigation studies have shown that adding nitric oxide to stored blood has several beneficial effects that could lead to a better stored blood product. Management has identified the estimated $4 billion dollar US blood market as a strategic product development project that will add significant value to Nu-Med.
Nu-Med Plus Inc. Announces New Proprietary Source for Low Cost Nitric Oxide Technology
Marketwired - Tue May 03, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced through its continuous improvement process it has created a new environmentally conscious method of generating nitric oxide gas for use in its medical gas delivery systems. Nitric oxide is a medically essential gas that is presently used in Neonate Hypoxia therapy (inadequate oxygen level in newborns), pulmonary treatments and may have future applications for a variety of other diseases and complications that are currently being investigated.
Nu-Med Plus Inc. Files Utility Patent for Low Cost Inhaled Nitric Oxide Technology
Marketwired - Tue Jan 26, 7:02AM CST
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced filing for a utility patent as continuation of its provisional patent which covers its low cost Nitric Oxide delivery technology.
Nu-Med Plus submits patent application for portable rapid distribution inhaled nitric oxide generator
M2 - Thu Jan 21, 5:14AM CST
Medical device company Nu-Med Plus (OTCBB:NUMD) announced on Wednesday that it has filed a patent for its new portable rapid distribution Nitric Oxide generating technology.
Nu-Med Plus, Inc. Applies for Patent on Portable Rapid Distribution Inhaled Nitric Oxide Generator
Marketwired - Wed Jan 20, 7:01AM CST
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced its patent filing for its new portable rapid distribution Nitric Oxide generating technology.
Nu-Med Plus reports newly developed inhaled nitric oxide generation system
M2 - Fri Jan 15, 6:27AM CST
Medical device company Nu-Med Plus (OTCBB:NUMD) said on Thursday that it has developed a new delivery system and formulation for the generation of inhaled nitric oxide for potential therapeutic use outside hospital and clinical environments.
Nu-Med Plus Develops Portable Rapid Distribution Nitric Oxide Generator
Marketwired - Thu Jan 14, 7:01AM CST
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced the development of a new delivery system and formulation for the generation of inhaled nitric oxide for potential therapeutic use outside the hospital and clinical environment. The newly developed system uses the thermal decomposition of a complex compound as the source of nitric oxide.
Nu-Med Plus, Inc. Raises Funding for Completion of Inhaled Nitric Oxide (INO) Clinical Unit
Marketwired - Tue Dec 08, 7:00AM CST
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has received interim funding thru the guidance of Smith Corporate Services to accelerate the completion of its INO clinical device designed for low cost use in out-patient and medical office settings.
Nu-Med Plus Contacted by Global Medical Healthcare Provider
Marketwired - Wed Sep 09, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has been contacted by a major producer of gases for Industry, Health and the Environment to discuss Nu-Med Plus's approach to Inhaled Nitric Oxide(NO) delivery.
Nu-Med Plus Announces the Addition of Keith L. Merrell as Their Chief Financial Officer
Marketwired - Tue Aug 04, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced that Keith L. Merrell has accepted the position of Chief Financial Officer replacing Mark Christensen.
Nu-Med Plus Announces New Methodology Using Nitric Oxide for Diabetic Wound Healing
Marketwired - Tue Jul 28, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced today that it has created the design and methodology by which Nitric Oxide (NO) may well be safely delivered, at optimal levels, to facilitate in the therapeutic healing of chronic diabetic foot ulcers and wounds.
Nu-Med Plus, Inc. Selects NT Associates as Its Strategic Public Relations Partner
Marketwired - Tue Jul 14, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has selected New York based corporate advisory firm NT Associates as its strategic public relations partner. NT Associates will be responsible for directing and executing a corporate plan for increased awareness and expansion of Nu-Med Plus, Inc. and its Inhaled Nitric Oxide products throughout the financial arena.
Nu-Med Plus Draws Global Attention as MERS, SARS and Bird Flu Threats Continue to Increase
Marketwired - Tue Jul 07, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has drawn worldwide attention with the increased threats to national economies coming from the spread of MERS, SARS and the Bird Flu.
Nu-Med Plus Announces Increased Patient Safety of Portable Inhaled Nitric Oxide Delivery
Marketwired - Tue Jun 30, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced that a visual indicator has been created that increases the safe therapeutic delivery of nitric oxide. The indicator is a quick visual check to ensure that by-products of the delivery of nitric oxide are not present in potentially toxic levels.
Nu-Med Plus, Inc. Selects Affinity Advisors, LLC as Their Strategic Public Relations Partner
Marketwired - Tue Jun 16, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has selected New York based corporate advisory firm Affinity Advisors as its strategic public relations partner. Affinity Advisors will be responsible for strategizing and executing a corporate plan for increased awareness and expansion of Nu-Med Plus, Inc. and its Inhaled Nitric Oxide products throughout the financial arena.
Nu-Med Plus Announces Computer Based Analyzer for Their Portable Inhaled Nitric Oxide System
Marketwired - Tue May 19, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has completed the development of a computer based analyzer and calibration software to complement their Portable/Rechargeable Inhaled Nitric Oxide unit. The completion of the analyzer is another step in providing a total solution for the administration of nitric oxide in a non-hospital setting. It is designed to be intuitive and simple to use.
Nu-Med Plus, Inc. Applies for Patent on Portable/Rechargeable Inhaled Nitric Oxide Delivery System
Marketwired - Tue May 05, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced its patent filing for its Portable Inhaled Nitric Oxide delivery technology.
Nu-Med Plus Announces the Addition of Charles Ivester M.D., Ph.D., to Their Medical Advisory Board
Marketwired - Tue Apr 28, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced the selection of Charles Ivester M.D., Ph.D. to their Medical Advisory Board.
Nu-Med Plus elects Mark Christensen as CFO
M2 - Tue Apr 21, 8:42AM CDT
Medical device company Nu-Med Plus (OTCBB:NUMD) disclosed on Tuesday the addition of Mark Christensen MPrA, CPA as its chief financial officer.
Nu-Med Plus Announces Investigational Study of Stored Blood as a New Path for Their NO Devices
Marketwire Canada - Tue May 10, 7:02AM CDT
SALT LAKE CITY, UT--(Marketwired - May 10, 2016) - Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announces they are embarking on a new investigational study applying their patent pending nitric oxide delivery devices to the protection of stored blood. Prior investigation studies have shown that adding nitric oxide to stored blood has several beneficial effects that could lead to a better stored blood product. Management has identified the estimated $4 billion dollar US blood market as a strategic product development project that will add significant value to Nu-Med.
Nu-Med Plus Inc. Announces New Proprietary Source for Low Cost Nitric Oxide Technology
Marketwired - Tue May 03, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced through its continuous improvement process it has created a new environmentally conscious method of generating nitric oxide gas for use in its medical gas delivery systems. Nitric oxide is a medically essential gas that is presently used in Neonate Hypoxia therapy (inadequate oxygen level in newborns), pulmonary treatments and may have future applications for a variety of other diseases and complications that are currently being investigated.
Nu-Med Plus Inc. Files Utility Patent for Low Cost Inhaled Nitric Oxide Technology
Marketwired - Tue Jan 26, 7:02AM CST
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced filing for a utility patent as continuation of its provisional patent which covers its low cost Nitric Oxide delivery technology.
Nu-Med Plus submits patent application for portable rapid distribution inhaled nitric oxide generator
M2 - Thu Jan 21, 5:14AM CST
Medical device company Nu-Med Plus (OTCBB:NUMD) announced on Wednesday that it has filed a patent for its new portable rapid distribution Nitric Oxide generating technology.
Nu-Med Plus, Inc. Applies for Patent on Portable Rapid Distribution Inhaled Nitric Oxide Generator
Marketwired - Wed Jan 20, 7:01AM CST
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced its patent filing for its new portable rapid distribution Nitric Oxide generating technology.
Nu-Med Plus reports newly developed inhaled nitric oxide generation system
M2 - Fri Jan 15, 6:27AM CST
Medical device company Nu-Med Plus (OTCBB:NUMD) said on Thursday that it has developed a new delivery system and formulation for the generation of inhaled nitric oxide for potential therapeutic use outside hospital and clinical environments.
Nu-Med Plus Develops Portable Rapid Distribution Nitric Oxide Generator
Marketwired - Thu Jan 14, 7:01AM CST
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced the development of a new delivery system and formulation for the generation of inhaled nitric oxide for potential therapeutic use outside the hospital and clinical environment. The newly developed system uses the thermal decomposition of a complex compound as the source of nitric oxide.
Nu-Med Plus, Inc. Raises Funding for Completion of Inhaled Nitric Oxide (INO) Clinical Unit
Marketwired - Tue Dec 08, 7:00AM CST
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has received interim funding thru the guidance of Smith Corporate Services to accelerate the completion of its INO clinical device designed for low cost use in out-patient and medical office settings.
Nu-Med Plus Contacted by Global Medical Healthcare Provider
Marketwired - Wed Sep 09, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has been contacted by a major producer of gases for Industry, Health and the Environment to discuss Nu-Med Plus's approach to Inhaled Nitric Oxide(NO) delivery.
Nu-Med Plus Announces the Addition of Keith L. Merrell as Their Chief Financial Officer
Marketwired - Tue Aug 04, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced that Keith L. Merrell has accepted the position of Chief Financial Officer replacing Mark Christensen.
Nu-Med Plus Announces New Methodology Using Nitric Oxide for Diabetic Wound Healing
Marketwired - Tue Jul 28, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced today that it has created the design and methodology by which Nitric Oxide (NO) may well be safely delivered, at optimal levels, to facilitate in the therapeutic healing of chronic diabetic foot ulcers and wounds.
Nu-Med Plus, Inc. Selects NT Associates as Its Strategic Public Relations Partner
Marketwired - Tue Jul 14, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has selected New York based corporate advisory firm NT Associates as its strategic public relations partner. NT Associates will be responsible for directing and executing a corporate plan for increased awareness and expansion of Nu-Med Plus, Inc. and its Inhaled Nitric Oxide products throughout the financial arena.
Nu-Med Plus Draws Global Attention as MERS, SARS and Bird Flu Threats Continue to Increase
Marketwired - Tue Jul 07, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has drawn worldwide attention with the increased threats to national economies coming from the spread of MERS, SARS and the Bird Flu.
Nu-Med Plus Announces Increased Patient Safety of Portable Inhaled Nitric Oxide Delivery
Marketwired - Tue Jun 30, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced that a visual indicator has been created that increases the safe therapeutic delivery of nitric oxide. The indicator is a quick visual check to ensure that by-products of the delivery of nitric oxide are not present in potentially toxic levels.
Nu-Med Plus, Inc. Selects Affinity Advisors, LLC as Their Strategic Public Relations Partner
Marketwired - Tue Jun 16, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which investigates and develops medical applications of new technologies in the medical field, has selected New York based corporate advisory firm Affinity Advisors as its strategic public relations partner. Affinity Advisors will be responsible for strategizing and executing a corporate plan for increased awareness and expansion of Nu-Med Plus, Inc. and its Inhaled Nitric Oxide products throughout the financial arena.
Nu-Med Plus Announces Computer Based Analyzer for Their Portable Inhaled Nitric Oxide System
Marketwired - Tue May 19, 7:01AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device development company, announced it has completed the development of a computer based analyzer and calibration software to complement their Portable/Rechargeable Inhaled Nitric Oxide unit. The completion of the analyzer is another step in providing a total solution for the administration of nitric oxide in a non-hospital setting. It is designed to be intuitive and simple to use.
Nu-Med Plus, Inc. Applies for Patent on Portable/Rechargeable Inhaled Nitric Oxide Delivery System
Marketwired - Tue May 05, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced its patent filing for its Portable Inhaled Nitric Oxide delivery technology.
Nu-Med Plus Announces the Addition of Charles Ivester M.D., Ph.D., to Their Medical Advisory Board
Marketwired - Tue Apr 28, 7:00AM CDT
Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced the selection of Charles Ivester M.D., Ph.D. to their Medical Advisory Board.
Nu-Med Plus elects Mark Christensen as CFO
M2 - Tue Apr 21, 8:42AM CDT
Medical device company Nu-Med Plus (OTCBB:NUMD) disclosed on Tuesday the addition of Mark Christensen MPrA, CPA as its chief financial officer.
